Eighty cocaine ( n = 80 ) and alcohol dependent , treatment-seeking subjects were randomly assigned to receive either two monthly extended-release injections of naltrexone or two matching placebo injections in an 8-week clinical trial , with weekly medical management plus cognitive behavioral therapy visits .